Kentucky Retirement Systems Insurance Trust Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Kentucky Retirement Systems Insurance Trust Fund’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Sell	4,980 -23	-0.5%	-$1.26K	0.02%	479
2026 Q1	$283K	Hold	5,003	–	–	0.02%	476
2025 Q4	$297K	Hold	5,003	–	–	0.02%	477
2025 Q3	$271K	Sell	5,003 -131	-3%	-$7.49K	0.02%	484
2025 Q2	$282K	Sell	5,134 -356	-6%	-$21K	0.02%	474
2025 Q1	$388K	Buy	+5,490	New	+$369K	0.03%	454

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Kentucky Retirement Systems Insurance Trust Fund's BMRN Position: Q2 2026 in Review

Kentucky Retirement Systems Insurance Trust Fund reduced its BioMarin Pharmaceuticals (BMRN) stake by 0.46% in Q2 2026, selling an estimated $1.26K and leaving 4,980 shares worth $285K. The position accounts for 0.02% of the portfolio, ranked #479.

Kentucky Retirement Systems Insurance Trust Fund first reported a position in BMRN in Q1 2025 and has held it in 6 quarters since. The position peaked at $388K in Q1 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Kentucky Retirement Systems Insurance Trust Fund held 4,980 shares of BioMarin Pharmaceuticals worth $285K as of Q2 2026.
Kentucky Retirement Systems Insurance Trust Fund sold 23 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $1.26K.
BioMarin Pharmaceuticals made up 0.02% of Kentucky Retirement Systems Insurance Trust Fund's portfolio in Q2 2026, its #479 holding.
Kentucky Retirement Systems Insurance Trust Fund first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Kentucky Retirement Systems Insurance Trust Fund's BioMarin Pharmaceuticals position peaked at $388K in Q1 2025.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Kentucky Retirement Systems Insurance Trust Fund's 13F filing for Q2 2026, filed 14 Aug 2026.